The aims of the present study were to:
- Investigate the feasibility of using a therapeutic gaming system (REHAB@HOME), based on Kinect, to augment upper extremity neurorehabilitation services.
- Provide preliminary evidence of clinical efficacy of the approach in increasing arm activity and health related quality of life of persons post stroke or with MS.
The objective of this pilot study was to assess the feasibility of using a therapeutic gaming system (REHAB@HOME), based on Kinect, to augment upper extremity neurorehabilitation services. A secondary objective was to provide preliminary evidence of clinical efficacy of the approach in increasing arm activity and health related quality of life of persons post stroke or with multiple sclerosis (MS).
A pilot single-blind randomized controlled trial was carried out in an inpatient and ambulatory care at a rehabilitation center. Twenty persons with multiple sclerosis (n=16) or chronic poststroke (n=4) receiving rehabilitation at the center, able to flex shoulder and elbow at least 45 degrees, participated in the study.
An intervention group received Serious Games-based upper extremity therapy for a total of 12 sessions (4-5 sessions, lasting 40 minutes, per week) and the control played the same amount of time with commercial exergames of the Wii. Both groups received their usual rehabilitation services as well as game playing.
- Serious games Behavioral
Other Names: virtual reality games Intervention Desc: Participants played serious games developed for Kinect in the the EU FP7 STREP Project REHAB@HOME N. 306113 ARM 1: Kind: Experimental Label: Serious games Description: The experimental group received Serious Games-based upper extremity therapy through Kinect
- Exergames Behavioral
Other Names: Wii game console Intervention Desc: Participants played exergames existent in the Wii game console ARM 1: Kind: Experimental Label: Exergames Description: The control played the same amount of time with commercial exergames of the Wii
- Allocation: Randomized
- Masking: Single Blind (Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
|Type||Measure||Time Frame||Safety Issue|
|Primary||9 Hole peg test||10 months||No|
|Primary||Box and Block test||10 months||No|
|Secondary||Short Form 12||10 months||No|
|Secondary||the EQ-5D visual analogue scale (EQ-VAS)||10 months||No|